Table 3.
Pre- and postoperative number of glaucoma medications in the CT and GATT with and without phacoemulsification.
| Preoperative | 1 Week | 1 Month | 3 Months | 6 Months | 12 Months | 24 Months | |
|---|---|---|---|---|---|---|---|
| CT, mean (median) ± SD |
4.11 (4) ± 0.99 (n = 27) |
1.93 (2) ± 1.27 (n = 27) |
2.11 (2) ± 1.37 (n = 27) |
2.37 (2) ± 1.22 (n = 27) |
2.50 (2) ± 1.32 (n = 24) |
2.80 (3) ± 1.57 (n = 20) |
2.88 (3) ± 1.54 (n = 16) |
| GATT, mean (median) ± SD |
4.00 (4) ± 1.03 (n = 53) |
1.42 (1) ± 1.51 (n = 53) |
1.68 (2) ± 1.55 (n = 53) |
1.72 (2) ± 1.58 (n = 50) |
1.82 (2) ± 1.61 (n = 49) |
1.87 (2) ± 1.61 (n = 45) |
1.97 (2) ± 1.73 (n = 35) |
| p-Value | NA | 0.139 | 0.222 | 0.070 | 0.081 | * 0.018 | 0.095 |
| CT with phacoemulsification, mean (median) ± SD |
3.69 (4) ± 1.07 (n = 13) |
1.85 (2) ± 1.35 (n = 13) |
2.23 (2) ± 1.19 (n = 13) |
2.31 (2) ± 1.26 (n = 13) |
2.42 (2) ± 1.38 (n = 12) |
2.63 (3.5) ± 1.65 (n = 8) |
3.14 (4) ± 1.55 (n = 7) |
| GATT with phacoemulsification, mean (median) ± SD |
4.03 (4) ± 0.75 (n = 30) |
1.60 (1.5) ± 1.52 (n = 30) |
1.57 (1) ± 1.56 (n = 30) |
1.57 (1) ± 1.50 (n = 30) |
1.73 (1.5) ± 1.63 (n = 30) |
1.79 (1.5) ± 1.61 (n = 28) |
2.00 (2) ± 1.80 (n = 21) |
| p-Value | NA | 0.766 | 0.225 | 0.164 | 0.249 | 0.227 | 0.206 |
| CT without phacoemulsification, mean (median) ± SD |
4.50 (4.5) ± 0.73 (n = 14) |
2.00 (2) ± 1.20 (n = 14) |
2.00 (2) ± 1.51 (n = 14) |
2.43 (2) ± 1.18 (n = 14) |
2.58 (2) ± 1.26 (n = 12) |
2.92 (3) ± 1.50 (n = 12) |
2.67 (2) ± 1.49 (n = 9) |
| GATT without phacoemulsification, mean (median) ± SD |
3.96 (4) ± 1.30 (n = 23) |
1.17 (0) ± 1.46 (n = 23) |
1.77 (2) ± 1.54 (n = 22) |
1.91 (2) ± 1.65 (n = 20) |
1.95 (2) ± 1.57 (n = 19) |
2.00 (2) ± 1.61 (n = 17) |
1.93 (2) ± 1.62 (n = 14) |
| p-Value | NA | 0.165 | 0.688 | 0.356 | 0.202 | 0.09 | 0.306 |
CT, conventional trabeculotomy; GATT, gonioscopy-assisted transluminal trabeculotomy; SD, standard deviation, * p < 0.05.